Corporate News – Metis Techbio –H (7666.HK)
Market Performance
- The share price closed 6.62 % higher during a 24‑hour period ending at 09:13 PM Central Europe on Tuesday, 20 October 2026.
- Current trading price: HKD 11.19 on major exchanges.
- Outstanding shares: 1.2 billion.
- Market capitalisation: HKD 14.1 billion.
- 24‑hour trading volume: approximately HKD 103.7 million.
- Since the close of the previous month, the stock has declined 23.25 %.
- 200‑day simple moving average: HKD 14.21.
- 52‑week high: HKD 29.98 (13 May 2026).
- 52‑week low: HKD 9.46 (30 July 2026).
Recent Corporate Development
Metis Techbio Co. Ltd‑H announced a partnership with Eli Lilly.
- The collaboration focuses on lipid‑nanoparticle (LNP) drug‑delivery technology.
- The agreement may involve up to US$1 billion in total value.
- Metis will receive an upfront payment and may earn milestone and royalty payments linked to development, regulatory approval, and commercial performance of products arising from the collaboration.
- The partnership aims to develop new LNP architectures that improve therapeutic efficacy across multiple disease areas.
- The deal highlights Metis’s expanding role in advanced drug‑delivery solutions and its alliance with a leading global pharmaceutical company.
Related Stock Movements (Last 24 Hours)
| Symbol | Exchange | Price Change | Current Price | Market Cap | P/E Ratio | Notes |
|---|---|---|---|---|---|---|
| 0548.HK | Hong Kong | –1.2 % | HKD 6.56 | HKD 16.8 bn | 14.26 | Slight decline |
| 002583.SZ | Shenzhen | 0 % | CNY 8 | CNY 14.4 bn | — | Significant institutional inflows |
| 0325.HK | Hong Kong | +2.94 % | HKD 70.6 | HKD 16.8 bn | 18.66 | Positive momentum in e‑commerce |
| 000778.SZ | Shenzhen | 0 % | CNY 3.58 | CNY 14.4 bn | 15.76 | Flat trading |
| 002171.SZ | Shenzhen | 0 % | CNY 9.12 | CNY 14.4 bn | 33.05 | Flat trading |
These movements reflect broader sectoral dynamics and investor sentiment across the listed companies.
